regards to patients, that thinking in economical terms can be combined with our hippocratic oath. J BERLIN Professor ofAnaesthesiology Postfach 834144 D·W4320 Hattingen Ruhr 13, FRG
Drug-induced epistaxis?
I read with interest the article on drug-induced epistaxis by Watson and Shenoi (March 1990 JRSM, p 162) .This article highlighted an association between the use of non-steroidal anti-inflammatory drugs (NSAIDs) and epistaxis. The authors reported that 32% of their patients were using NSAIDs. In this group aspirin accounted for 37% of drug use with a range of other NSAIDs accounting for the other 63%.
A prospective study of 52 adult patients admitted with epistaxis to the Otolaryngology Department of Glasgow Royal Infirmary (32 male, 20 female, mean age 61 years) revealed that 44% (23 patients) were taking NSAIDs (unpublished observation). Whilst this confirms the findings of Watson and Shenoi, a striking difference is found on examination of the type of medication used by the Glasgow patients. In the Glasgow group aspirin accounted for 87% of NSAID use with other NSAIDs accounting for only 13%.
Analysis of the reported reasons for the use of these medications shows that 13% had been prescribed for arthritis, 13% had been prescribed as cardiovascular prophylaxis and the remaining 74% were being selfadministered. The reasons for this self-medication with aspirin and aspirin-containing proprietary medicines were diverse and ranged from headaches and the common cold to aches and pains and 'hangover cure'! In the Birmingham group 66% of NSAIDs were antiarthritic medications and this is consistent with the reported high incidence of arthritis in that study. In the Glasgow group however, arthritis was considerably less prevalent. It seems therefore that interesting demographic differences exist between the Glasgow and Birmingham patients.
Watson and Shenoi recommended that doctors and patients should be made aware of the possible risk of epistaxis associated with NSAID use. The results of the Glasgow study strongly suggest that the selfmedicating general public need to be made aware of this potential side effect of aspirin-based proprietary remedies. G W MCGARRY Department of Otolaryngology Glasgow Royal Infirmary Glasgow G4 OSF
Holistic medicine
A keen conclusion about holistic medicine now (Quinn, June 1990 JRSM, p 343) is the need to make its practitioners as appropriately qualified within a practice as soon as possible. I see a distinct role for a new service specialist whom I describe as a practice pharmaco-physiologist, who would work with a dietitian. A ready-proven health care worker -a physiological measurement technician or a suitably specialist nurse -could be chosen. His/her further training would be in physiology, learning to use selected tests, eg standing/lying blood pressure, urinalysis, etc. with precision and objectivity. The routines would both add to follow-up cover and allow. from near home, the collection of information to assess 'a code of practice on the appropriateness of medical intervention' for diseases and long-term drug therapies with validated physical measures of progress.
The practice social worker might, ideally, complete the 'holistic baseline' through agreed sociability assessments (including at least one home visit), and so complete a 'holistic baseline' for groups the practice has resources to follow up.
In sum, this could be a real advance from within the community towards fulfilling one of the logical but 'general' Main Recommendations ofthe Griffiths report, 1988, para 51, quoted above. Would it not be advancing medicine to validate and use these general procedures? (patients attending the physiologist need not all be 'treatment' cases; a minority could be 'check-up requesters', life insurance candidates etc.)
Since outcome measurement is an agreed Government policy, following the above report, which recommends resourcing treatment evaluation Cpassim'), the basic service should be cost-repayable.
I emphasize that the family doctor would be team leader in requesting such special assessments, and executant in prescribing treatment, or referring a patient to a hospital consultant. The new service could, however, help again duringretum to community care.
The main role of a treatment-physiologist would be to measure progress indicators in chronic risk patients on modified therapy or after operations through clinic visits within a health centre, and report unexpected deterioration to the GP. W R DUNHAM Clinical Pathologist St Catherine's Hospital Birkenhead, Merseyside L42 OLQ From Da Vinci to Harvey J R Novell states in his article (June 1990 JRSM, P 396) that Harvey 'correctly described the function of the venous valves in preventing centripetal flow in which role they were fundamental to his account of the circulation of the blood' -and that 'Fabricius suggested the function of the valves was to control centrifugal flow in the veins.' I find these two statements confusing. If control of centrifugal flow means preventing 'back flow' in the veins, then, surely, that is correct interpretation and not 'opposite to their true function'; and 'preventing centripetal flow' attributed to Harvey, is a mis-statement.
In this connection mention needs to be made of the fact that, whereas Charles Etienne's is the first published description of the valves of the veins, it was Fra Paolo Sarpi who informed his great friend Fabricius of the presence and the true function of the valves. In a letter Sarpi wrote: 'with great pleasure I realised that I had discovered certain things in connection with the circulation of the blood in the body of animals and the structure and use of the valves (de osteolis sanguinis)' Fabricius acknowledged the source of this information in his De Venarum Osteolis', T JAMES 16Spring Gardens Pinelands, Cape ofGood Hope 7405, South Africa Reference
